
NOTICE & NEWS
EYEREUM OPHTHALMIC CLINIC
ESCRS 37TH CONGRESS OF THE ESCRS PARIS
OCULUS - PENTACAM Holladay Report
[Technical meeting] SMILE Treatment developer visited EYEREUM
2018.12.07
4768
Dr. Mark Bischoff (R&d director) and Ronald Wendenburg(Product director)
from Carl ZEISS Headquarter visited EYEREUM.


▲ Dr. JinHyoung Kim and Carl Zeiss directors
The purpose of visiting was for observing
EYEREUM's Low Energy SMILE Treatment and technical consultation.
▼ Dr. David Sung Yong Kang




We hope this meeting will contribute to further the evolution of SMILE treatment!
EYEREUM always try to make your eye surgery safer.
By globalization of Low Energy SMILE,
We will provide safe surgery for foreign patients as well as Koreans.
EYEREUM OPHTHALMIC CLINIC™
EYEREUM OPHTHALMIC CLINIC